Stifel Financial’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
112,243
+44,579
| +66% | +$153K | ﹤0.01% | 2913 |
|
|
2025
Q1 | $151K | Sell |
67,664
-3,850
| -5% | -$8.59K | ﹤0.01% | 3234 |
|
|
2024
Q4 | $210K | Sell |
71,514
-3,300
| -4% | -$9.67K | ﹤0.01% | 3148 |
|
|
2024
Q3 | $195K | Sell |
74,814
-27,563
| -27% | -$71.7K | ﹤0.01% | 3148 |
|
|
2024
Q2 | $303K | Sell |
102,377
-6,900
| -6% | -$20.4K | ﹤0.01% | 2913 |
|
|
2024
Q1 | $495K | Sell |
109,277
-868
| -0.8% | -$3.93K | ﹤0.01% | 2614 |
|
|
2023
Q4 | $629K | Buy |
110,145
+45,522
| +70% | +$260K | ﹤0.01% | 2441 |
|
|
2023
Q3 | $297K | Sell |
64,623
-3,190
| -5% | -$14.7K | ﹤0.01% | 2795 |
|
|
2023
Q2 | $438K | Sell |
67,813
-4,809
| -7% | -$31.1K | ﹤0.01% | 2598 |
|
|
2023
Q1 | $548K | Sell |
72,622
-1,961
| -3% | -$14.8K | ﹤0.01% | 2465 |
|
|
2022
Q4 | $756K | Buy |
74,583
+326
| +0.4% | +$3.3K | ﹤0.01% | 2212 |
|
|
2022
Q3 | $734K | Buy |
74,257
+12,482
| +20% | +$123K | ﹤0.01% | 2178 |
|
|
2022
Q2 | $658K | Buy |
61,775
+22,450
| +57% | +$239K | ﹤0.01% | 2298 |
|
|
2022
Q1 | $383K | Buy |
39,325
+504
| +1% | +$4.91K | ﹤0.01% | 2728 |
|
|
2021
Q4 | $555K | Sell |
38,821
-31,699
| -45% | -$453K | ﹤0.01% | 2538 |
|
|
2021
Q3 | $1.41M | Buy |
70,520
+48,515
| +220% | +$972K | ﹤0.01% | 1822 |
|
|
2021
Q2 | $484K | Buy |
22,005
+14,736
| +203% | +$324K | ﹤0.01% | 2604 |
|
|
2021
Q1 | $247K | Buy |
+7,269
| New | +$247K | ﹤0.01% | 2903 |
|